True or False: The cobas® EGFR Mutation Test v2 has been approved by the FDA to detect EGFR mutations in non-small cell lung cancer (NSCLC) patients, as an aid in selecting therapy with an EGFR tyrosine kinase inhibitor (TKI).

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 176 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Liquid Biopsy Assays. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Liquid Biopsy Assays (online CE course)

True or False: The cobas® EGFR Mutation Test v2 has been approved by the FDA to detect EGFR mutations in non-small cell lung cancer (NSCLC) patients, as an aid in selecting therapy with an EGFR tyrosine kinase inhibitor (TKI).

Select true or false